TransMedics Group Inc

TMDX

Company Profile

  • Business description

    TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

  • Contact

    200 Minuteman Road
    AndoverMA01810
    USA

    T: +1 978 552-0900

    https://www.transmedics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    898

Stocks News & Analysis

stocks

Avoid this overvalued ASX healthcare share

Expensive healthcare share limited by its core addressable market.
stocks

AI driving growth for ASX tech share

ASX tech share raises funds to facilitate customer AI spend.
stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,828.2019.300.22%
CAC 408,203.434.140.05%
DAX 4024,433.06183.16-0.74%
Dow JONES (US)50,872.1186.100.17%
FTSE 10010,227.33145.87-1.41%
HKSE24,281.32284.58-1.16%
NASDAQ25,678.82250.84-0.97%
Nikkei 22564,681.39735.24-1.12%
NZX 50 Index13,183.8120.27-0.15%
S&P 5007,386.6519.08-0.26%
S&P/ASX 2008,623.3031.900.37%
SSE Composite Index3,979.0930.94-0.77%

Market Movers